L

Lexeo Therapeutics Inc
NASDAQ:LXEO

Watchlist Manager
Lexeo Therapeutics Inc
NASDAQ:LXEO
Watchlist
Price: 6.28 USD 3.97% Market Closed
Market Cap: 207.7m USD
Have any thoughts about
Lexeo Therapeutics Inc?
Write Note

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of LXEO.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LXEO Intrinsic Value
Not Available
L
Base Case Scenario
How do you feel about LXEO?
Bearish
Neutral
Bullish

Fundamental Analysis

6.28 USD
+3.97%
+3.97%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Lexeo Therapeutics Inc
US
Biotechnology
Market Cap
207.7m USD
IPO
Nov 3, 2023
Employees
53
United States of America
Market Cap
207.7m USD
Industry
Biotechnology
IPO
Nov 3, 2023
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Lexeo Therapeutics Inc

Provide an overview of the primary business activities
of Lexeo Therapeutics Inc.

What unique competitive advantages
does Lexeo Therapeutics Inc hold over its rivals?

What risks and challenges
does Lexeo Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Lexeo Therapeutics Inc recently?

Show all valuation multiples
for Lexeo Therapeutics Inc.

Provide P/S
for Lexeo Therapeutics Inc.

Provide P/E
for Lexeo Therapeutics Inc.

Provide P/OCF
for Lexeo Therapeutics Inc.

Provide P/FCFE
for Lexeo Therapeutics Inc.

Provide P/B
for Lexeo Therapeutics Inc.

Provide EV/S
for Lexeo Therapeutics Inc.

Provide EV/GP
for Lexeo Therapeutics Inc.

Provide EV/EBITDA
for Lexeo Therapeutics Inc.

Provide EV/EBIT
for Lexeo Therapeutics Inc.

Provide EV/OCF
for Lexeo Therapeutics Inc.

Provide EV/FCFF
for Lexeo Therapeutics Inc.

Provide EV/IC
for Lexeo Therapeutics Inc.

Show me price targets
for Lexeo Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Lexeo Therapeutics Inc?

How accurate were the past Revenue estimates
for Lexeo Therapeutics Inc?

What are the Net Income projections
for Lexeo Therapeutics Inc?

How accurate were the past Net Income estimates
for Lexeo Therapeutics Inc?

What are the EPS projections
for Lexeo Therapeutics Inc?

How accurate were the past EPS estimates
for Lexeo Therapeutics Inc?

What are the EBIT projections
for Lexeo Therapeutics Inc?

How accurate were the past EBIT estimates
for Lexeo Therapeutics Inc?

Compare the revenue forecasts
for Lexeo Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Lexeo Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Lexeo Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Lexeo Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Lexeo Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Lexeo Therapeutics Inc with its peers.

Analyze the financial leverage
of Lexeo Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Lexeo Therapeutics Inc.

Provide ROE
for Lexeo Therapeutics Inc.

Provide ROA
for Lexeo Therapeutics Inc.

Provide ROIC
for Lexeo Therapeutics Inc.

Provide ROCE
for Lexeo Therapeutics Inc.

Provide Gross Margin
for Lexeo Therapeutics Inc.

Provide Operating Margin
for Lexeo Therapeutics Inc.

Provide Net Margin
for Lexeo Therapeutics Inc.

Provide FCF Margin
for Lexeo Therapeutics Inc.

Show all solvency ratios
for Lexeo Therapeutics Inc.

Provide D/E Ratio
for Lexeo Therapeutics Inc.

Provide D/A Ratio
for Lexeo Therapeutics Inc.

Provide Interest Coverage Ratio
for Lexeo Therapeutics Inc.

Provide Altman Z-Score Ratio
for Lexeo Therapeutics Inc.

Provide Quick Ratio
for Lexeo Therapeutics Inc.

Provide Current Ratio
for Lexeo Therapeutics Inc.

Provide Cash Ratio
for Lexeo Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Lexeo Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Lexeo Therapeutics Inc?

What is the current Free Cash Flow
of Lexeo Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Lexeo Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Lexeo Therapeutics Inc

Balance Sheet Decomposition
Lexeo Therapeutics Inc

Current Assets 124.3m
Cash & Short-Term Investments 121.5m
Other Current Assets 2.8m
Non-Current Assets 15.5m
PP&E 12.3m
Other Non-Current Assets 3.3m
Current Liabilities 17.2m
Accounts Payable 3.8m
Accrued Liabilities 12.6m
Other Current Liabilities 844k
Non-Current Liabilities 9m
Long-Term Debt 1.2m
Other Non-Current Liabilities 7.8m
Efficiency

Earnings Waterfall
Lexeo Therapeutics Inc

Revenue
0 USD
Operating Expenses
-68.5m USD
Operating Income
-68.5m USD
Other Expenses
2.1m USD
Net Income
-66.4m USD

Free Cash Flow Analysis
Lexeo Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LXEO Profitability Score
Profitability Due Diligence

Lexeo Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Lexeo Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

LXEO Solvency Score
Solvency Due Diligence

Lexeo Therapeutics Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Lexeo Therapeutics Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LXEO Price Targets Summary
Lexeo Therapeutics Inc

Wall Street analysts forecast LXEO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LXEO is 22.73 USD with a low forecast of 16.16 USD and a high forecast of 29.4 USD.

Lowest
Price Target
16.16 USD
157% Upside
Average
Price Target
22.73 USD
262% Upside
Highest
Price Target
29.4 USD
368% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LXEO?

Click here to dive deeper.

Dividends

Lexeo Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LXEO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LXEO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More